
Laxana8 mg
Renata Limited
Lubiprostone is a locally-acting chloride channel activator indicated for: Chronic Idiopathic Constipation (CIC) in adults — an established and more.
Lubiprostone is a locally-acting chloride channel activator indicated for:
Lubiprostone is not indicated for constipation caused by mechanical gastrointestinal obstruction, and it is not a first-line agent — it is generally used after lifestyle measures (fluid, fiber, exercise) and/or other laxatives have proven inadequate.
Lubiprostone should be taken orally, twice daily, with food and water, to reduce the likelihood of nausea. Capsules should be swallowed whole and not chewed.
| Indication | Adult Dose | Frequency |
|---|---|---|
| Chronic Idiopathic Constipation (CIC) | 24 mcg | Twice daily, with food |
| IBS-C (women ≥ 18 years) | 8 mcg | Twice daily, with food |
| Opioid-Induced Constipation (OIC) | 24 mcg | Twice daily, with food |
A reduced starting dose (e.g., 16 mcg twice daily for CIC or OIC, and 8 mcg once daily for IBS-C, adjusted per severity) may be considered in patients with moderate to severe hepatic impairment, based on prescribing information; individualize per clinical judgment.
No dedicated dose adjustment has been established; use with routine clinical monitoring.
Take the next dose at the regular scheduled time; do not double the dose to make up for a missed one.
The most commonly reported adverse effects of Lubiprostone include:
Seek prompt medical attention for severe or persistent diarrhea, signs of an allergic reaction, or chest tightness/breathing difficulty.
Lubiprostone is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.